|
Clinical performance of a comprehensive novel liquid biopsy test for identifying non-small cell lung cancer (NSCLC) patients for treatment with osimertinib. |
|
|
Honoraria - AstraZeneca; Axiom Healthcare Strategies; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech; Lilly; Merck; Takeda |
Consulting or Advisory Role - AstraZeneca; Axiom Healthcare Strategies; Axiom Healthcare Strategies; Bristol-Myers Squibb; Celgene; EMD Serono; EMD Serono; Merck; Merck; Novartis; Takeda |
Research Funding - Array BioPharma (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst) |
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck; Merck Serono; Novartis; Takeda |
|
|
Honoraria - AstraZeneca; Bristol-Myers Squibb; MSD; Roche; Takeda |
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD Oncology; Novartis; Pfizer; Takeda |
Research Funding - Ono Pharmaceutical; Pfizer; Roche; Takeda |
|
|
|
Stock and Other Ownership Interests - AstraZeneca |
|
|
|
Stock and Other Ownership Interests - AstraZeneca |
|
|
Employment - AstraZeneca; AstraZeneca (I) |
Stock and Other Ownership Interests - AstraZeneca; AstraZeneca (I) |
|
|
|
Stock and Other Ownership Interests - AstraZeneca |
|
|
|
Stock and Other Ownership Interests - AstraZeneca |
|
|
No Relationships to Disclose |
|
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
|
|
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD Oncology; Pfizer; Roche |
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Roche |
Research Funding - Boehringer Ingelheim (Inst); Pfizer (Inst); Roche (Inst) |
|
|
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly/ImClone; Loxo; Merck; Nektar; Takeda; Tesaro |
Research Funding - Abbvie (Inst); Advaxis (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Genmab (Inst); Merck (Inst); Merck (Inst); Pfizer (Inst); Takeda (Inst); Vertex (Inst) |
Travel, Accommodations, Expenses - AstraZeneca |
|
|
|
Stock and Other Ownership Interests - AstraZeneca |
|
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |